Additional file 3: Table S2. The normalized fluorescent intensities (NFIs) of each lectin for the serum proteins from NSCLC groups and control group
Additional file 1: Table S1. General description of directly measured plasma protein (GPs) and IgG (...
Additional file 2: Table S2. Associations of the studied glycan traits with the disease status (COPD...
<p>(A) The three panels (from top to bottom) are typical serum N-glycan profiles from healthy contro...
Additional file 2: Table S1. Sugar-binding specificities of the 37 lectins used in the lectin microa...
Additional file 1: Figure S1. The layout of the lectin microarrays. Each lectin was spotted in tripl...
Expression levels of biomarker candidates in serum collected from patients with NSCLC (nâ=â94) a...
Additional file 10. Â Diseases and biofunctions of lung cancers by ingenuity pathway analysis (IPA)
Successful therapy of the non-small cell lung carcinoma (NSCLC) depends on its early detection, and ...
Candidate lung cancer biomarkers (nâ=â179) identified through LC/MS analysis
Additional file 2: Table 1. Description of total serum N-glycan UHPLC measured peaks. Table 2. Descr...
Lung cancer is the leading cause of cancer death and non-small cell lung carcinoma (NSCLC) accountin...
Additional file 2: Table S2. LC-ESI-MS quantification of OVCAR-3 cell lines released by PNGase F via...
Additional file 3: Table S3. Associations of glycan traits with the COPD severity (cases in differen...
Previous studies have suggested occurrence of altered serum glycan profiles in patients with lung ca...
Supplementary material 1. Table S1. Clinicodemographic characteristics of healthy individuals (cont...
Additional file 1: Table S1. General description of directly measured plasma protein (GPs) and IgG (...
Additional file 2: Table S2. Associations of the studied glycan traits with the disease status (COPD...
<p>(A) The three panels (from top to bottom) are typical serum N-glycan profiles from healthy contro...
Additional file 2: Table S1. Sugar-binding specificities of the 37 lectins used in the lectin microa...
Additional file 1: Figure S1. The layout of the lectin microarrays. Each lectin was spotted in tripl...
Expression levels of biomarker candidates in serum collected from patients with NSCLC (nâ=â94) a...
Additional file 10. Â Diseases and biofunctions of lung cancers by ingenuity pathway analysis (IPA)
Successful therapy of the non-small cell lung carcinoma (NSCLC) depends on its early detection, and ...
Candidate lung cancer biomarkers (nâ=â179) identified through LC/MS analysis
Additional file 2: Table 1. Description of total serum N-glycan UHPLC measured peaks. Table 2. Descr...
Lung cancer is the leading cause of cancer death and non-small cell lung carcinoma (NSCLC) accountin...
Additional file 2: Table S2. LC-ESI-MS quantification of OVCAR-3 cell lines released by PNGase F via...
Additional file 3: Table S3. Associations of glycan traits with the COPD severity (cases in differen...
Previous studies have suggested occurrence of altered serum glycan profiles in patients with lung ca...
Supplementary material 1. Table S1. Clinicodemographic characteristics of healthy individuals (cont...
Additional file 1: Table S1. General description of directly measured plasma protein (GPs) and IgG (...
Additional file 2: Table S2. Associations of the studied glycan traits with the disease status (COPD...
<p>(A) The three panels (from top to bottom) are typical serum N-glycan profiles from healthy contro...
DOI
Add to ORKG